StockData
Prestige Consumer Healthcare Inc. logo

Prestige Consumer Healthcare Inc. (PBH) stock

PBHNYSEPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3024% below fair value
$50.62+2.40 (+4.98%)

Close on Nov 18, 2026Market cap $2.40BP/E 14.2Yield –

Prestige Consumer Healthcare profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Prestige Consumer Healthcare's profit margin for the twelve months ending Jun 30, 2026 was 15.6%. For fiscal 2026 it was 17.5%, against 18.9% the year before. The highest annual figure on record is 32.6% in fiscal 2018.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2026Mar 31, 202617.5%−1.4
FY2025Mar 31, 202518.9%+0.3
FY2024Mar 31, 202418.6%+25.9
FY2023Mar 31, 2023-7.3%−26.2
FY2022Mar 31, 202218.9%+1.4
FY2021Mar 31, 202117.5%+2.7
FY2020Mar 31, 202014.8%+18.4
FY2019Mar 31, 2019-3.7%−36.3
FY2018Mar 31, 201832.6%+24.7
FY2017Mar 31, 20177.9%−4.5
FY2016Mar 31, 201612.4%+1.4
FY2015Mar 31, 201511.0%−1.2
FY2014Mar 31, 201412.2%+1.5
FY2013Mar 31, 201310.6%+2.2
FY2012Mar 31, 20128.4%−0.2
FY2011Mar 31, 20118.7%−2.3
FY2010Mar 31, 201011.0%–

Quarterly profit margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q1 FY2027CQ2 2026Jun 30, 202611.0%−8.0
Q4 FY2026CQ1 2026Mar 31, 202619.1%+2.2
Q3 FY2026CQ4 2025Dec 31, 202516.5%−4.5
Q2 FY2026CQ3 2025Sep 30, 202515.4%−3.8
Q1 FY2026CQ2 2025Jun 30, 202519.0%+0.7
Q4 FY2025CQ1 2025Mar 31, 202516.9%−0.9
Q3 FY2025CQ4 2024Dec 31, 202421.0%+2.3
Q2 FY2025CQ3 2024Sep 30, 202419.2%+0.5
Q1 FY2025CQ2 2024Jun 30, 202418.4%−0.7
Q4 FY2024CQ1 2024Mar 31, 202417.9%+102.0
Q3 FY2024CQ4 2023Dec 31, 202318.8%−0.1
Q2 FY2024CQ3 2023Sep 30, 202318.7%+1.1
Q1 FY2024CQ2 2023Jun 30, 202319.1%−0.9
Q4 FY2023CQ1 2023Mar 31, 2023-84.1%−103.7
Q3 FY2023CQ4 2022Dec 31, 202218.9%+0.6
Q2 FY2023CQ3 2022Sep 30, 202217.6%+1.2
Q1 FY2023CQ2 2022Jun 30, 202219.9%−1.5
Q4 FY2022CQ1 2022Mar 31, 202219.5%+4.6
Q3 FY2022CQ4 2021Dec 31, 202118.3%+1.2
Q2 FY2022CQ3 2021Sep 30, 202116.4%−2.4
Q1 FY2022CQ2 2021Jun 30, 202121.5%+2.4
Q4 FY2021CQ1 2021Mar 31, 202114.9%+0.2
Q3 FY2021CQ4 2020Dec 31, 202017.1%+1.4
Q2 FY2021CQ3 2020Sep 30, 202018.8%+4.8
Q1 FY2021CQ2 2020Jun 30, 202019.1%+4.4
Q4 FY2020CQ1 2020Mar 31, 202014.7%+72.5
Q3 FY2020CQ4 2019Dec 31, 201915.8%−0.1
Q2 FY2020CQ3 2019Sep 30, 201914.0%+1.1
Q1 FY2020CQ2 2019Jun 30, 201914.6%+1.0
Q4 FY2019CQ1 2019Mar 31, 2019-57.8%−42.3
Q3 FY2019CQ4 2018Dec 31, 201815.8%−100.5
Q2 FY2019CQ3 2018Sep 30, 201812.9%+1.0
Q1 FY2019CQ2 2018Jun 30, 201813.6%+0.4
Q4 FY2018CQ1 2018Mar 31, 2018-15.5%−20.1
Q3 FY2018CQ4 2017Dec 31, 2017116.3%+101.7
Q2 FY2018CQ3 2017Sep 30, 201711.9%−3.1
Q1 FY2018CQ2 2017Jun 30, 201713.2%–
Q4 FY2017CQ1 2017Mar 31, 20174.6%–
Q3 FY2017CQ4 2016Dec 31, 201614.6%–
Q2 FY2017CQ3 2016Sep 30, 201615.0%–

More Prestige Consumer Healthcare figures

See a number that looks wrong?